Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Utz Brands
UTZ
$1.25B
| $1.03M | ﹤0.01% |
75,000
-724,600
| -91% | -$8.39M |
|
2702
Gray Television
GTN
$552M
| $1.03M | ﹤0.01% |
73,726
-38,912
| -35% | -$499K |
|
2703
Cinemark Holdings
CNK
$4.32B
| $1.02M | ﹤0.01% |
88,387
-46,333
| -34% | -$629K |
|
2704
Enovis
ENOV
$1.53B
| $1.02M | ﹤0.01% |
21,270
+2,838
| +15% | +$125K |
|
|
CHNG
2705
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $1.02M | ﹤0.01% |
91,064
-655,720
| -88% | -$7.36M |
|
2706
Safety Insurance
SAFT
$1.52B
| $1.02M | ﹤0.01% |
13,388
+1,298
| +11% | +$102K |
|
2707
CALL
LyondellBasell Industries
LYB
$19.2B
| $1.02M | ﹤0.01% |
15,500
-11,900
| -43% | -$708K |
|
2708
Apple Hospitality REIT
APLE
$3.82B
| $1.02M | ﹤0.01% |
105,328
-12,616
| -11% | -$120K |
|
2709
Cooper-Standard Automotive
CPS
$558M
| $1.02M | ﹤0.01% |
76,683
+10,492
| +16% | +$127K |
|
2710
United Fire Group
UFCS
$1.4B
| $1.02M | ﹤0.01% |
36,650
+18,504
| +102% | +$522K |
|
|
DBD
2711
PUT
DELISTED
Diebold Nixdorf Incorporated
DBD
| $1.02M | ﹤0.01% |
167,600
-1,600
| -0.9% | -$7.89K |
|
2712
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.57B
| $1.01M | ﹤0.01% |
+42,500
| New | +$911K |
|
2713
PUT
Goodyear
GT
$1.85B
| $1.01M | ﹤0.01% |
113,500
-394,800
| -78% | -$3M |
|
|
NBIS
2714
PUT
Nebius Group N.V.
NBIS
$47.7B
| $1.01M | ﹤0.01% |
20,300
-25,100
| -55% | -$1.01M |
|
2715
CALL
NovoCure
NVCR
$1.91B
| $1.01M | ﹤0.01% |
17,100
| – | – |
|
2716
Heron Therapeutics
HRTX
$92.9M
| $1.01M | ﹤0.01% |
68,794
+25,337
| +58% | +$416K |
|
2717
PG&E
PCG
$38.5B
| $1.01M | ﹤0.01% |
113,945
-3,153
| -3% | -$34.4K |
|
|
AXDX
2718
DELISTED
Accelerate Diagnostics
AXDX
| $1.01M | ﹤0.01% |
6,662
+3,615
| +119% | +$356K |
|
2719
CALL
Roper Technologies
ROP
$39.8B
| $1.01M | ﹤0.01% |
+2,600
| New | +$932K |
|
|
2720
PUT
Roper Technologies
ROP
$39.8B
| $1.01M | ﹤0.01% |
+2,600
| New | +$932K |
|
|
VIVO
2721
DELISTED
Meridian Bioscience Inc
VIVO
| $1.01M | ﹤0.01% |
43,174
-9,894
| -19% | -$143K |
|
2722
Bio-Techne
TECH
$11.3B
| $1M | ﹤0.01% |
15,192
-77,460
| -84% | -$4.64M |
|
|
NP
2723
DELISTED
Neenah, Inc. Common Stock
NP
| $1M | ﹤0.01% |
20,230
+1,660
| +9% | +$79.8K |
|
2724
Ambev
ABEV
$46.4B
| $1M | ﹤0.01% |
379,202
+78,475
| +26% | +$185K |
|
2725
First Majestic Silver
AG
$9.07B
| $1M | ﹤0.01% |
100,656
-28,836
| -22% | -$244K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.